RxDoctor Payments DataLook up a doctor →

KRAZATI: payments to doctors

Payments that named KRAZATI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.1M
Providers
6,701
Transactions
17,492
Average per transaction
$119

The per-transaction average — $119 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,701 providers the average total is $310, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Mirati Therapeutics, Inc.$1,995,80496.1%
E.r. Squibb & Sons, L.L.C.$80,2043.9%
← All drugs & devices